Siemens is planning to list its 40 billion euro ($47.94 billion) healthcare unit Healthineers in March, two people close to the matter said, as the group hopes to execute the deal while market conditions are favourable.
Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely within Britain’s state-funded health service.
The St. Louis Post-Dispatch just dropped a helluva news nugget. Citing public records, the paper reports that Amazon “has gained approval to become a wholesale distributor from a number of state pharmaceutical boards.” That might mean that Amazon wants to sell prescription drugs. Then again, it might not.
Yescarta is the second gene therapy product approved in the U.S.
“How many different cell types are there in the human body? And how do these differences develop? Nobody really knows,” says Professor Stein Aerts from KU Leuven/VIB. But thanks to a new method developed by his team, that may be about to change.